How has been the historical performance of Kingfa Science?

Answer:The historical performance of Kingfa Science shows a consistent growth trend in net sales and profitability over the years leading up to March 2025.

Breakdown:
Kingfa Science has demonstrated significant growth in net sales, increasing from 701.52 Cr in March 2019 to 1,744.69 Cr in March 2025. This upward trajectory reflects a robust expansion strategy, with total operating income following a similar pattern, reaching 1,744.69 Cr in March 2025 compared to 701.52 Cr in March 2019. The company's operating profit (PBDIT) has also improved markedly, rising from 39.30 Cr in March 2019 to 234.45 Cr in March 2025, indicating enhanced operational efficiency. Profit before tax has surged from 29.22 Cr in March 2019 to 206.08 Cr in March 2025, while profit after tax has increased from 19.06 Cr to 152.86 Cr over the same period. The earnings per share (EPS) have seen a remarkable rise from 15.74 in March 2019 to 126.23 in March 2025, reflecting the company's strong profitability. On the balance sheet, total assets grew from 551.40 Cr in March 2019 to 994.44 Cr in March 2024, while total liabilities increased from 551.40 Cr to 994.44 Cr, indicating a balanced growth in both assets and liabilities. Cash flow from operating activities, however, has fluctuated, showing a net cash inflow of 2.00 Cr in March 2024, up from a net outflow of 6.00 Cr in March 2023. Overall, Kingfa Science's financial performance illustrates a strong upward trend in sales, profits, and shareholder value over the past several years.